Skip to main content

Table 3 EPHX2 K55R genotype distribution in incident CHD and early-onset CHD cases

From: Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

 

CHD

(n = 435)

Controls

(n = 271)

HW

P value

CHD

≤55 years

(n = 117)

Controls

≤55 years

(n = 91)

P value

Genotype

       

A/A

357 (82.1)

219 (80.8)

  

92 (78.6)

75 (82.4)

 

A/G + G/G

78 (17.9)

52 (19.2)

0.527

0.675

25 (21.4)

16 (17.6)

0.496

Allele frequencies

       

A

0.91

0.90

  

0.89

0.91

 

G

0.09

0.10

  

0.11

0.09

 
  1. Data presented as absolute (%) genotype frequency and allele frequency. HW: P-value for Hardy-Weinberg equilibrium test.